KNTE

Kinnate Biopharma Inc. Common Stock

Delisted

KNTE was delisted on the 2nd of April, 2024.

76 hedge funds and large institutions have $465M invested in Kinnate Biopharma Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
+5
Holders Change %
+7.04%
% of All Funds
1.2%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.09%
New
16
Increased
21
Reduced
19
Closed
11
Calls
$518K
Puts
Net Calls
+$518K
Net Calls Change
+$541K
Name Holding Trade Value Shares
Change
Shares
Change %
VA
76
VR Adviser
New York
-$13.7M -773,014 Closed
N
77
Natixis
France
-$11.9M -672,500 Closed
PHS
78
PFM Health Sciences
California
-$4.68M -264,293 Closed
Janus Henderson Group
79
Janus Henderson Group
United Kingdom
-$2.27M -128,182 Closed
Russell Investments Group
80
Russell Investments Group
United Kingdom
-$984K -55,568 Closed
HS
81
HighVista Strategies
Massachusetts
-$820K -46,264 Closed
D.E. Shaw & Co
82
D.E. Shaw & Co
New York
-$248K -13,989 Closed
ProShare Advisors
83
ProShare Advisors
Maryland
-$209K -11,778 Closed
Susquehanna International Group
84
Susquehanna International Group
Pennsylvania
-$206K -11,640 Closed
DCM
85
Dupont Capital Management
Delaware
-$156K -8,804 Closed
SG Americas Securities
86
SG Americas Securities
New York
-$137K -7,707 Closed